AAMI three-lens brief
Evidence-based stock research on AAMI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 10.0pp over 30 days.
- Ex-dividend date 2026-09-11.
AAMI closed at $92.05 (-0.49%) as of 2026-09-11. Market cap: $3.27B. P/E (trailing) 32.6. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 10.0pp over 30 days.. Last quarter: Revenue $183.20M, free cash flow $231.09M.
Why three lenses on AAMI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AAMIacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AAMI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AAMI brief"></iframe>